{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:39:39Z","timestamp":1773193179778,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.diabet.2006.11.012","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T11:17:49Z","timestamp":1174994269000},"page":"189-196","source":"Crossref","is-referenced-by-count":12,"title":["Effect of\u00a0cerivastatin on\u00a0peripheral capillary permeability to\u00a0albumin and\u00a0peripheral nerve function in\u00a0diabetic rats"],"prefix":"10.1016","volume":"33","author":[{"given":"F.E.","family":"Cohen-Boulakia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tarhzaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.E.","family":"Valensi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Lestrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Behar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2006.11.012_bib1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.97.8.736","article-title":"Coronary artery responses to physiological stimuli are improved by deferoxamine but not by l-arginine in noninsulin dependent diabetic patients with angiographically normal coronary arteries and no other risk factors","volume":"97","author":"Nitenberg","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2006.11.012_bib2","series-title":"Acetylcholine-induced skin vasodilatation is altered in non diabetic and diabetic overweight patients. In 20th Eur. Conf. on Microcirculation","first-page":"55","author":"Valensi","year":"1998"},{"issue":"suppl 1","key":"10.1016\/j.diabet.2006.11.012_bib3","first-page":"26","article-title":"Clinical implications of impaired microcirculation","volume":"14","author":"Valensi","year":"1995","journal-title":"Int. Angiol."},{"key":"10.1016\/j.diabet.2006.11.012_bib4","first-page":"389","article-title":"Changes in capillary permeability in diabetic patients","volume":"17","author":"Valensi","year":"1997","journal-title":"Clin Hemorrheol"},{"key":"10.1016\/j.diabet.2006.11.012_bib5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/(SICI)1096-9136(199610)13:10<882::AID-DIA247>3.0.CO;2-4","article-title":"Effect of a purified micronised flavonoid fraction on the capillary filtration of albumin in diabetic patients","volume":"13","author":"Valensi","year":"1996","journal-title":"Diabet. Med."},{"key":"10.1016\/j.diabet.2006.11.012_bib6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diabetes.36.7.813","article-title":"Increased vascular permeability in spontaneously diabetic BB\/W rats and in rats with mild versus severe streptozotocin-induced diabetes. Prevention by aldose reductase inhibitors","volume":"36","author":"Williamson","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2006.11.012_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.RES.35.4.544","article-title":"Increased metabolic turnover rate and transcapillary escape rate of albumin in essential hypertension","volume":"35","author":"Parving","year":"1974","journal-title":"Circ. Res."},{"key":"10.1016\/j.diabet.2006.11.012_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0026-0495(98)90231-1","article-title":"Increased capillary filtration of albumin in diabetic patients. Relation with gender, hypertension, macroangiopathy and neuropathy","volume":"47","author":"Valensi","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.diabet.2006.11.012_bib9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/brain\/104.4.779","article-title":"Experimental cold injury to peripheral nerve","volume":"104","author":"Nukada","year":"1981","journal-title":"Brain"},{"key":"10.1016\/j.diabet.2006.11.012_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ahj.2004.06.027","article-title":"Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients","volume":"149","author":"John","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.diabet.2006.11.012_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9150(03)00296-X","article-title":"Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles","volume":"170","author":"Wang","year":"2003","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.diabet.2006.11.012_bib12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0008-6363(00)00146-2","article-title":"Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability","volume":"47","author":"Koh","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.diabet.2006.11.012_bib13","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0002-9440(10)63728-5","article-title":"Simvastatin inhibits leukocyte accumulation and vascular parmeability in the retinas of rats with streptozotocin-induced diabetes","volume":"164","author":"Miyahara","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.diabet.2006.11.012_bib14","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2337\/diabetes.54.10.2977","article-title":"Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of STZ induced diabetic rats","volume":"54","author":"Mooradian","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2006.11.012_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-8227(03)00123-2","article-title":"Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models","volume":"61","author":"Cameron","year":"2003","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.diabet.2006.11.012_bib16","article-title":"Nerve electrophysiological changes in rats with early induced diabetes","author":"Tarhzaoui","year":"2006","journal-title":"J. Diabetes Complic."},{"key":"10.1016\/j.diabet.2006.11.012_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00308713","article-title":"Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. Effect of STZ-induced diabetes","volume":"79","author":"Thomas","year":"1990","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.diabet.2006.11.012_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00689989","article-title":"Morphological and morphometric study of peripheral nerves from rats with streptozotocin-induced diabetes mellitus","volume":"53","author":"Zemp","year":"1981","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.diabet.2006.11.012_bib19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/meta.2000.6754","article-title":"In vivo sequential study of skeletal muscle capillary permeability in diabetic rats. Effect of anthocyanosides","volume":"49","author":"Cohen-Boulakia","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.diabet.2006.11.012_bib20","first-page":"75","article-title":"Study of capillary filtration and lymphatic resorption by double labelling albumin and red blood cells in cyclic edema and diabetes","volume":"4","author":"Cohen-Boulakia","year":"1993","journal-title":"Eur J Lymphol"},{"key":"10.1016\/j.diabet.2006.11.012_bib21","doi-asserted-by":"crossref","first-page":"18J","DOI":"10.1016\/S0002-9149(98)00433-0","article-title":"Preclinical and clinical pharmacology of cerivastatin","volume":"27","author":"Bischoff","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.diabet.2006.11.012_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00125-003-1099-3","article-title":"Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model","volume":"46","author":"Ota","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2006.11.012_bib23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0735-1097(03)00926-4","article-title":"Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models","volume":"42","author":"Susic","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.diabet.2006.11.012_bib24","first-page":"804","article-title":"A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats","volume":"98","author":"Sicard","year":"2005","journal-title":"Arch Mal Coeur"},{"key":"10.1016\/j.diabet.2006.11.012_bib25","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/01.ATV.19.12.2894","article-title":"Simvastatin inhibits leukocyte\u2013endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats","volume":"19","author":"Pruefer","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.diabet.2006.11.012_bib26","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/hq0801.094222","article-title":"In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products","volume":"21","author":"Diomede","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.diabet.2006.11.012_bib27","first-page":"1","article-title":"Evoked action potentials and conduction velocity in human sensory nerves","volume":"3","author":"Buchtal","year":"1966","journal-title":"Brain Res."},{"key":"10.1016\/j.diabet.2006.11.012_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mus.20474","article-title":"Prolonged ischemic conduction failure after reperfusion in diabetic nerve","volume":"33","author":"Baba","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.diabet.2006.11.012_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1529-8027.2002.02004.x","article-title":"Aggravated reperfusion injury in STZ-diabetic nerve","volume":"7","author":"Nukada","year":"2002","journal-title":"J Periph Nerve Syst"},{"issue":"4B","key":"10.1016\/j.diabet.2006.11.012_bib30","first-page":"115","article-title":"Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor","volume":"82","author":"Von Keutz","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.diabet.2006.11.012_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2003.08.013","article-title":"Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats","volume":"194","author":"Schaefer","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.diabet.2006.11.012_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/toxsci\/kfi305","article-title":"Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity","volume":"88","author":"Seachrist","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.diabet.2006.11.012_bib33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s002280050562","article-title":"Statins and peripheral neuropathy","volume":"54","author":"Jeppesen","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.diabet.2006.11.012_bib34","first-page":"690","article-title":"Neuromuscular toxicity in nephrotic patients treated with fluvastatin","volume":"15","author":"Gazerin","year":"2002","journal-title":"J. Nephrol."},{"key":"10.1016\/j.diabet.2006.11.012_bib35","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.58.9.1333","article-title":"Statins and risk of polyneuropathy a case control study","volume":"58","author":"Gaist","year":"2002","journal-title":"Neurology"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S126236360700050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S126236360700050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T15:54:42Z","timestamp":1546962882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S126236360700050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S126236360700050X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2006.11.012","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}